The cases that were cited by FDA were not new.
We continue to have a robust pipeline at Abbott. There are a number of exciting things coming up...
People did need ample time to be able to transition to an alternative therapy.
Patent litigation has been amicably resolved and the parties have agreed to dismiss the patent claims.
